The Fox Chase Chemical Diversity Center, Inc. (FCCDC)

 

The Fox Chase Chemical Diversity Center Announces the Funding and Award of a Phase I SBIR Grant of $297,000 from the National Institutes of Health

 

Doylestown, PA. September 6, 2011 – FCCDC is pleased to announce the funding and award of a Phase I SBIR grant of $297,000 from the National Institutes of Health (1 R43 CA156781-01: Riluzole Prodrugs for Melanoma and ALS). This project is part of a collaboration with Prof. Suzie Chen of Rutgers University, with possible application for the treatment of melanoma.